These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6480771)

  • 21. Novel drug of choice in Eaton-Lambert syndrome.
    Lundh H; Nilsson O; Rosén I
    J Neurol Neurosurg Psychiatry; 1983 Jul; 46(7):684-5. PubMed ID: 6310051
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of 4-aminopyridine in horse plasma using gas-liquid chromatography.
    Hendricks HL; Bush PB; Kitzman JV; Booth NH
    J Chromatogr; 1984 Apr; 287(2):429-32. PubMed ID: 6725464
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of 3,4-diaminopyridine-induced coronary oscillation by adenyl compounds.
    Yoshinaka Y; Uchida Y
    Eur J Pharmacol; 1986 Aug; 127(3):173-8. PubMed ID: 3758179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotoxicity of quinolinate in the rat nucleus basalis magnocellularis.
    Boegman RJ; Metcalf R; Riopelle RJ; Ludwin SK
    Brain Res; 1987 Aug; 417(2):315-20. PubMed ID: 2958107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Sanders DB; Howard JF; Massey JM
    Ann N Y Acad Sci; 1993 Jun; 681():588-90. PubMed ID: 8357206
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of 3,4-diaminopyridine on acetylcholine release at the frog neuromuscular junction.
    Durant NN; Marshall IG
    Eur J Pharmacol; 1980 Oct; 67(2-3):201-8. PubMed ID: 6970132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tetrahydroaminoacridine, 3,4 diaminopyridine and physostigmine: direct comparison of effects on memory in aged primates.
    Bartus RT; Dean RL
    Neurobiol Aging; 1988; 9(4):351-6. PubMed ID: 3185853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The myasthenic syndrome: anaesthesia in a patient treated with 3.4 diaminopyridine.
    Telford RJ; Hollway TE
    Br J Anaesth; 1990 Mar; 64(3):363-6. PubMed ID: 1970263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine.
    Gibson GE; Manger T
    Biochem Pharmacol; 1988 Nov; 37(21):4191-6. PubMed ID: 2847755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminopyridine block of transient potassium current.
    Thompson S
    J Gen Physiol; 1982 Jul; 80(1):1-18. PubMed ID: 6288835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F.
    Siegel LS; Johnson-Winegar AD; Sellin LC
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).
    Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():811-6. PubMed ID: 9668334
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
    Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
    Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,4-Diaminopyridine may improve neuromuscular block during botulism.
    Friggeri A; Marçon F; Marciniak S; Lemaire-Hurtel AS; Seydi A; Ammenouche N; Levrard M; Mahjoub Y; Airapetian N; Tinturier F; Petitjean M; Dupont H
    Crit Care; 2013 Sep; 17(5):449. PubMed ID: 24007658
    [No Abstract]   [Full Text] [Related]  

  • 35. High-performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog.
    Kullberg MP; Dorrbecker B; Lennon J; Rowe E; Edelson J
    J Chromatogr; 1980 Jan; 187(1):264-70. PubMed ID: 7358819
    [No Abstract]   [Full Text] [Related]  

  • 36. Determination of 4-aminopyridine in plasma.
    Watson E
    Anal Biochem; 1981 May; 113(1):139-43. PubMed ID: 7270879
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of A 3,4-diaminopyridine in plasma by liquid chromatography with electrochemical detection using solid-phase extraction.
    Goulay-Dufaÿ S; Do B; Le Hoang MD; Raust JA; Graffard H; Guyon F; Pradeau D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):261-6. PubMed ID: 15135099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiographic and angioscopic observations of the arterial luminal changes induced by vasospasm.
    Uchida Y; Nakamura F; Tomaru T; Sonoki H; Sumino S; Sugimoto T
    Am Heart J; 1987 Nov; 114(5):1096-101. PubMed ID: 3673876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lycopodium clavatum exine microcapsules enable safe oral delivery of 3,4-diaminopyridine for treatment of botulinum neurotoxin A intoxication.
    Harris TL; Wenthur CJ; Diego-Taboada A; Mackenzie G; Corbitt TS; Janda KD
    Chem Commun (Camb); 2016 Mar; 52(22):4187-90. PubMed ID: 26906286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adenosine and calcium entry blockers on 3,4-diaminopyridine-induced rhythmic contractions in dog coronary artery.
    Nakazawa M; Mustafa SJ
    Eur J Pharmacol; 1988 May; 149(3):345-9. PubMed ID: 3409957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.